BRIEF-Galera Therapeutics Receives Written Notice From Nasdaq Indicating That Nasdaq Hearings Panel Determined To Delist Co’s Shares

Reuters06-03

June 3 (Reuters) - Galera Therapeutics Inc :

* GALERA THERAPEUTICS INC SAYS ON MAY 31, CO RECEIVED WRITTEN NOTICE FROM NASDAQ INDICATING THAT NASDAQ HEARINGS PANEL DETERMINED TO DELIST CO’S SHARES

* GALERA THERAPEUTICS INC SAYS TRADING IN CO’S SHARES OF COMMON STOCK ON NASDAQ WILL BE SUSPENDED EFFECTIVE AT OPEN OF TRADING ON JUNE 4 - SEC FILING

* GALERA THERAPEUTICS INC - UPON SUSPENSION ON NASDAQ, CO EXPECTS COMMON STOCK WILL BE QUOTED UNDER ITS EXISTING SYMBOL “GRTX” ON OTC

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment